- Home
- SOTK vs BYSI Comparison
SOTK vs BYSI Comparison
Compare SOTK & BYSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOTK
- BYSI
- Stock Information
- Founded
- SOTK 1975
- BYSI 2010
- Country
- SOTK United States
- BYSI United States
- Employees
- SOTK N/A
- BYSI N/A
- Industry
- SOTK Industrial Machinery/Components
- BYSI Biotechnology: Pharmaceutical Preparations
- Sector
- SOTK Technology
- BYSI Health Care
- Exchange
- SOTK Nasdaq
- BYSI Nasdaq
- Market Cap
- SOTK 58.5M
- BYSI 71.0M
- IPO Year
- SOTK 1987
- BYSI 2017
- Fundamental
- Price
- SOTK $3.68
- BYSI $2.29
- Analyst Decision
- SOTK Hold
- BYSI
- Analyst Count
- SOTK 1
- BYSI 0
- Target Price
- SOTK N/A
- BYSI N/A
- AVG Volume (30 Days)
- SOTK 5.4K
- BYSI 126.0K
- Earning Date
- SOTK 07-10-2025
- BYSI 08-11-2025
- Dividend Yield
- SOTK N/A
- BYSI N/A
- EPS Growth
- SOTK N/A
- BYSI N/A
- EPS
- SOTK 0.09
- BYSI N/A
- Revenue
- SOTK $20,606,116.00
- BYSI N/A
- Revenue This Year
- SOTK N/A
- BYSI N/A
- Revenue Next Year
- SOTK $9.53
- BYSI N/A
- P/E Ratio
- SOTK $40.34
- BYSI N/A
- Revenue Growth
- SOTK N/A
- BYSI N/A
- 52 Week Low
- SOTK $3.50
- BYSI $0.98
- 52 Week High
- SOTK $6.05
- BYSI $3.44
- Technical
- Relative Strength Index (RSI)
- SOTK 50.01
- BYSI 48.82
- Support Level
- SOTK $3.63
- BYSI $2.20
- Resistance Level
- SOTK $3.78
- BYSI $2.42
- Average True Range (ATR)
- SOTK 0.13
- BYSI 0.18
- MACD
- SOTK 0.00
- BYSI -0.06
- Stochastic Oscillator
- SOTK 52.38
- BYSI 13.71
About SOTK Sono-Tek Corporation
Sono-Tek Corp design and manufacture of ultrasonic coating systems for applying precise, thin film coatings to add functional properties, protect or strengthen surfaces on parts and components for the microelectronics/electronics, alternative energy, medical, industrial and emerging research & development/other markets. The company design and manufacture custom-engineered ultrasonic coating systems incorporating its patented technology, in combination with strong applications engineering knowledge, to assist its customers in achieving their desired coating solutions.
About BYSI BeyondSpring Inc.
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.